203 related articles for article (PubMed ID: 1348532)
21. [Nucleolus organizer regions in benign and malignant diseases of the exocrine pancreas--comparison with an analysis of the proliferation marker PCNA].
Reich O; Heinisch G; Justus J
Pathologe; 1993 Jan; 14(1):1-6. PubMed ID: 8095718
[No Abstract] [Full Text] [Related]
22. Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool.
Giuffrè G; Mormandi F; Barresi V; Bordi C; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(1):45-50. PubMed ID: 16584984
[TBL] [Abstract][Full Text] [Related]
23. Proliferating cell nuclear antigen (PCNA) in atypical and malignant meningiomas.
Zimmer C; Gottschalk J; Cervos-Navarro J; Martin H; Beil M; Jautzke G
Pathol Res Pract; 1992 Dec; 188(8):951-8. PubMed ID: 1363764
[TBL] [Abstract][Full Text] [Related]
24. An improved system for quantifying AgNOR and PCNA in canine tumors.
Hung LC; Pong VF; Cheng CR; Wong FI; Chu RM
Anticancer Res; 2000; 20(5A):3273-80. PubMed ID: 11062753
[TBL] [Abstract][Full Text] [Related]
25. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
26. Agnor as a marker of malignant transformation in odontogenic keratocysts.
Piloni MJ; Keszler A; Itoiz ME
Acta Odontol Latinoam; 2005; 18(1):37-42. PubMed ID: 16302459
[TBL] [Abstract][Full Text] [Related]
27. AgNOR, Ki-67 and PCNA expression in fibroepithelial tumours of the breast in correlation with morphological features.
Barwijuk-Machała M; Musiatowicz B; Cylwik J; Reszeć J; Augustynowicz A
Folia Morphol (Warsz); 2004 Feb; 63(1):133-5. PubMed ID: 15039920
[TBL] [Abstract][Full Text] [Related]
28. [Proteins associated with nucleolar organizer regions: practical application in tumor histopathology and relationship to biological properties of the tumor].
Dubenskaia LI; Bazhenov SM
Arkh Patol; 1992; 54(4):40-3. PubMed ID: 1444858
[TBL] [Abstract][Full Text] [Related]
29. AgNOR- and PCNA-studies in astrocytomas of the optic nerve.
Patt S; Giraldo M; Martin H
Zentralbl Pathol; 1994 Mar; 140(1):83-7. PubMed ID: 7515678
[TBL] [Abstract][Full Text] [Related]
30. Assessment of proliferative activity by AgNOR and PCNA in prostatic tissues of ram lambs implanted with zeranol.
Gulbahar MY; Yuksel H; Guvenc T; Okut H
Reprod Domest Anim; 2005 Oct; 40(5):468-74. PubMed ID: 16149954
[TBL] [Abstract][Full Text] [Related]
31. [Silver-stained Nucleolar Organizer Regions (AgNOR)].
Derenzini M; Trerè D
Pathologica; 2001 Apr; 93(2):99-105. PubMed ID: 11428299
[TBL] [Abstract][Full Text] [Related]
32. Proliferating cell nuclear antigen (PCNA) and nucleolar organiser regions in Hodgkin's disease: correlation with morphology.
Freeman J; Kellock DB; Yu CC; Crocker J; Levison DA; Hall PA
J Clin Pathol; 1993 May; 46(5):446-9. PubMed ID: 8100573
[TBL] [Abstract][Full Text] [Related]
33. [The significance of the nucleolus organizer region antigen for the differentiation of laryngeal dysplasias and laryngeal carcinoma].
Martin H; Greiner K; Beil M; Hufnagl P
HNO; 1996 Jan; 44(1):22-6. PubMed ID: 8819725
[TBL] [Abstract][Full Text] [Related]
34. Measurement of cellular proliferation in human prostate by AgNOR, PCNA, and SPF.
Sakr WA; Sarkar FH; Sreepathi P; Drozdowicz S; Crissman JD
Prostate; 1993; 22(2):147-54. PubMed ID: 7681206
[TBL] [Abstract][Full Text] [Related]
35. [The relationship between the prognosis of retinoblastoma and proliferating cell nuclear antigen and argyrophilic protein at nucleolus organizer regions].
Li D; Song X; Gao Y
Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):293-6. PubMed ID: 10451965
[TBL] [Abstract][Full Text] [Related]
36. Critical analysis of the methods commonly employed in the assessment of cell proliferation: advantages of the NOR silver-staining technique in routine cyto-histopathology.
Trerè D
Anal Cell Pathol; 1993 Jul; 5(4):191-201. PubMed ID: 8363981
[TBL] [Abstract][Full Text] [Related]
37. Nucleolar organizer regions in cutaneous tumours.
Egan MJ; Crocker J
J Pathol; 1988 Mar; 154(3):247-53. PubMed ID: 2450982
[TBL] [Abstract][Full Text] [Related]
38. Growth fraction in lung tumours determined by Ki67 immunostaining and comparison with AgNOR scores.
Soomro IN; Whimster WF
J Pathol; 1990 Nov; 162(3):217-22. PubMed ID: 2266458
[TBL] [Abstract][Full Text] [Related]
39. The proliferative activity in dysplasia and carcinoma in situ of the uterine cervix analyzed by proliferating cell nuclear antigen immunostaining and silver-binding argyrophilic nucleolar organizer region staining.
Kobayashi I; Matsuo K; Ishibashi Y; Kanda S; Sakai H
Hum Pathol; 1994 Feb; 25(2):198-202. PubMed ID: 7907076
[TBL] [Abstract][Full Text] [Related]
40. [Correlation between the grade of histological malignancy and nuclear positivity using the AgNOR technique in 6 cases of isolated bone NHL].
Cosimi MF; Casagranda I; Porta C; Moroni M; Orsi R; Nastasi G
Sangre (Barc); 1992 Oct; 37(5):399-402. PubMed ID: 1293782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
